Morey Blinder

Research output

Research output per year 1983 1983 1989 1990 1991 1998 1999 2001 2004 2006 2007 2008 2009 2010 2011 2013 2014 2018 2019 2022

• 48 Article
• 3 Comment/debate
• 2 Letter
• 1 Review article

Research output per year

Research output per year

Search results

• 2022

  Silent Infarcts, White Matter Integrity, and Oxygen Metabolic Stress in Young Adults With and Without Sickle Cell Trait

  Wang, Y., Guilliams, K. P., Fields, M. E., Fellah, S., Binkley, M. M., Reis, M., Vo, K. D., Chen, Y., Ying, C., Blinder, M., King, A. A., Hulbert, M. L., An, H., Lee, J. M. & Ford, A. L., Sep 1 2022, In: Stroke. 53, 9, p. 2887-2895 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Sickle Cell Trait 100%
  • Physiological Stress 81%
  • White Matter 62%
  • Infarction 57%
  • Young Adult 55%
  1 Scopus citations
• 2020

  Quality of life after pharmacomechanical catheter-directed thrombolysis for proximal deep venous thrombosis

  ATTRACT Trial Investigators, Jan 2020, In: Journal of Vascular Surgery: Venous and Lymphatic Disorders. 8, 1, p. 8-23.e18

  Research output: Contribution to journal › Article › peer-review

  • Venous Thrombosis 100%
  • Catheters 82%
  • Quality of Life 67%
  • Thigh 12%
  • Thrombosis 8%
  36 Scopus citations
• 2019

  Hydroxyurea reduces cerebral metabolic stress in patients with sickle cell anemia

  Fields, M. E., Guilliams, K. P., Ragan, D., Binkley, M. M., Mirro, A., Fellah, S., Hulbert, M. L., Blinder, M., Eldeniz, C., Vo, K., Shimony, J. S., Chen, Y., McKinstry, R. C., An, H., Lee, J. M. & Ford, A. L., May 30 2019, In: Blood. 133, 22, p. 2436-2444 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Hydroxyurea 100%
  • Physiological Stress 82%
  • Sickle Cell Anemia 75%
  • Metabolic 55%
  • Dioxygen 33%
  35 Scopus citations

• Plasmapheresis for Management of Antiphospholipid Syndrome in the Neurosurgical Patient

  Arias, E. J., Bruck, B., Vellimana, A. K., Eby, C., Reynolds, M. R., Blinder, M. A. & Zipfel, G. J., Apr 1 2019, In: Operative Neurosurgery. 16, 4, p. E124-E129

  Research output: Contribution to journal › Article › peer-review

  • Plasmapheresis 100%
  • Antiphospholipid Syndrome 99%
  • Thrombosis 42%
  • Moyamoya Disease 37%
  • Neurosurgical Procedures 36%
  1 Scopus citations
• 2018

  Acute graft-versus-host disease following lung transplantation in a patient with a novel TERT mutation

  Brestoff, J. R., Vessoni, A. T., Brenner, K. A., Uy, G. L., DiPersio, J. F., Blinder, M., Witt, C. A., Byers, D. E., Hachem, R. R., Truclock, E. P., Early, D. S., Anadkat, M. J., Musiek, A., Javidan-Nejad, C., Balfe, D. M., Rosman, I. S., Liu, C., Zhang, L., Despotis, G. J., Ruzinova, M. B., & 8 othersSehn, J. K., Amarillo, I., Heusel, J. W., Swat, W., Kim, B. S., Wartman, L. D., Yusen, R. D. & Batista, L. F. Z., May 1 2018, In: Thorax. 73, 5, p. 489-492 4 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Lung Transplantation 100%
  • Telomerase 97%
  • Graft vs Host Disease 90%
  • Pulmonary Fibrosis 66%
  • Mutation 48%
  7 Scopus citations

• Adherence to iron chelation therapy in patients who switched from deferasirox dispersible tablets to deferasirox film-coated tablets

  Cheng, W. Y., Said, Q., Hao, Y., Xiao, Y., Vekeman, F., Bobbili, P., Duh, M. S., Nandal, S. & Blinder, M., Nov 2 2018, In: Current Medical Research and Opinion. 34, 11, p. 1959-1966 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Deferasirox 100%
  • Chelation Therapy 88%
  • Tablets 58%
  • Iron 53%
  • Myelodysplastic Syndromes 20%
  4 Scopus citations
• 2017

  Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis

  Vedantham, S., Goldhaber, S. Z., Julian, J. A., Kahn, S. R., Jaff, M. R., Cohen, D. J., Magnuson, E., Razavi, M. K., Comerota, A. J., Gornik, H. L., Murphy, T. P., Lewis, L., Duncan, J. R., Nieters, P., Derfler, M. C., Filion, M., Gu, C. S., Kee, S., Schneider, J., Saad, N., & 10 othersBlinder, M., Moll, S., Sacks, D., Lin, J., Rundback, J., Garcia, M., Razdan, R., VanderWoude, E., Marques, V. & Kearon, C., Dec 7 2017, In: New England Journal of Medicine. 377, 23, p. 2240-2252 13 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Venous Thrombosis 100%
  • Catheters 82%
  • Control Groups 40%
  • Thrombosis 23%
  • Hemorrhage 19%
  413 Scopus citations
• 2015

  Age-Related Emergency Department Reliance in Patients with Sickle Cell Disease

  Blinder, M. A., Duh, M. S., Sasane, M., Trahey, A., Paley, C. & Vekeman, F., Oct 2015, In: Journal of Emergency Medicine. 49, 4, p. 513-522.e1

  Research output: Contribution to journal › Article › peer-review

  • Sickle Cell Anemia 100%
  • Hospital Emergency Service 73%
  • Health Care Costs 32%
  • Regression Analysis 12%
  • Pediatrics 11%
  43 Scopus citations
• 2014

  Exertional sickling: Questions and controversy

  Blinde, M. A. & Russel, S., Dec 3 2014, In: Hematology Reports. 6, 4, p. 66-70 5 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Exercise 100%
  • Sickle Cell Trait 89%
  • Sudden Death 63%
  • Sickle Hemoglobin 43%
  • Football 36%
  10 Scopus citations

• Systemic effects of subcutaneous heparin use in otolaryngology patients

  Blank, S. J., Grindler, D. J., Zerega, J., Blinder, M. & Nussenbaum, B., Dec 4 2014, In: Otolaryngology - Head and Neck Surgery (United States). 151, 6, p. 967-971 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Otolaryngology 100%
  • Heparin 80%
  • Partial Thromboplastin Time 34%
  • Head and Neck Neoplasms 29%
  • Hemorrhage 28%
  5 Scopus citations
• 2013

  Age-related treatment patterns in sickle cell disease patients and the associated sickle cell complications and healthcare costs

  Blinder, M. A., Vekeman, F., Sasane, M., Trahey, A., Paley, C. & Duh, M. S., May 2013, In: Pediatric Blood and Cancer. 60, 5, p. 828-835 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Chelation Therapy 100%
  • Sickle Cell Anemia 78%
  • Health Care Costs 64%
  • Iron 52%
  • Costs and Cost Analysis 22%
  78 Scopus citations

• Successful orthotopic liver transplantation in an adult patient with sickle cell disease and review of the literature

  Blinder, M. A., Geng, B., Lisker-Melman, M., Crippin, J. S., Korenblat, K., Chapman, W., Shenoy, S. & Field, J. J., 2013, In: Hematology Reports. 5, 1, p. 1-4 4 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Sickle Cell Anemia 100%
  • Liver Transplantation 83%
  • Intrahepatic Cholestasis 65%
  • Transplants 42%
  • Liver 35%
  13 Scopus citations
• 2011

  Abnormalities in cardiac structure and function in adults with sickle cell disease are not associated with pulmonary hypertension

  Knight-Perry, J. E., De Las Fuentes, L., Waggoner, A. D., Hoffmann, R. G., Blinder, M. A., Dávila-Román, V. G. & Field, J. J., Nov 2011, In: Journal of the American Society of Echocardiography. 24, 11, p. 1285-1290 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Sickle Cell Anemia 100%
  • Pulmonary Hypertension 90%
  • Right Ventricular Function 38%
  • Compliance 27%
  • Tricuspid Valve 12%
  13 Scopus citations

• Recurrent, severe wheezing is associated with morbidity and mortality in adults with sickle cell disease

  Cohen, R. T., Madadi, A., Blinder, M. A., Debaun, M. R., Strunk, R. C. & Field, J. J., Sep 2011, In: American journal of hematology. 86, 9, p. 756-761 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Respiratory Sounds 100%
  • Sickle Cell Anemia 99%
  • Asthma 71%
  • Morbidity 53%
  • Mortality 46%
  46 Scopus citations
• 2009

  Sustained response with rituximab in patients with thrombotic thrombocytopenic purpura: A report of 13 cases and review of the literature

  Ling, H. T., Field, J. J. & Blinder, M. A., Jul 2009, In: American journal of hematology. 84, 7, p. 418-421 4 p.

  Research output: Contribution to journal › Article › peer-review

  • Thrombotic Thrombocytopenic Purpura 100%
  • Rituximab 80%
  • Acquired Thrombotic thrombocytopenic purpura 31%
  • Autoantibodies 17%
  • Recurrence 10%
  52 Scopus citations

• Urinary cysteinyl leukotriene e ₄ is associated with increased risk for pain and acute chest syndrome in adults with sickle cell disease

  Field, J. J., Krings, J., White, N. L., Yan, Y., Blinder, M. A., Strunk, R. C. & Debaun, M. R., Mar 2009, In: American journal of hematology. 84, 3, p. 158-160 3 p.

  Research output: Contribution to journal › Article › peer-review

  • Acute Chest Syndrome 100%
  • Leukotriene E4 96%
  • cysteinyl-leukotriene 94%
  • Sickle Cell Anemia 71%
  • Pain 37%
  19 Scopus citations

• Urinary cysteinyl leukotriene E₄ significantly increases during pain in children and adults with sickle cell disease

  Field, J. J., Strunk, R. C., Knight-Perry, J. E., Blinder, M. A., Townsend, R. R. & DeBaun, M. R., Apr 2009, In: American journal of hematology. 84, 4, p. 231-233 3 p.

  Research output: Contribution to journal › Article › peer-review

  • Leukotriene E4 100%
  • cysteinyl-leukotriene 97%
  • Sickle Cell Anemia 73%
  • Pain 38%
  • Creatinine 35%
  24 Scopus citations
• 2008

  Laparoscopic versus open abdominal surgery in children with sickle cell disease is associated with a shorter hospital stay

  Goers, T., Panepinto, J., DeBaun, M., Blinder, M., Foglia, R., Oldham, K. T. & Field, J. J., Mar 2008, In: Pediatric Blood and Cancer. 50, 3, p. 603-606 4 p.

  Research output: Contribution to journal › Article › peer-review

  • Sickle Cell Anemia 100%
  • Length of Stay 69%
  • Acute Chest Syndrome 60%
  • Child 39%
  • Splenectomy 28%
  30 Scopus citations

• Reticulocyte hemoglobin content

  Mast, A. E., Blinder, M. A. & Dietzen, D. J., Apr 2008, In: American journal of hematology. 83, 4, p. 307-310 4 p.

  Research output: Contribution to journal › Article › peer-review

  • Reticulocytes 100%
  • Iron 69%
  • Hemoglobins 67%
  • Erythrocytes 37%
  • Kidney 19%
  108 Scopus citations
• 2007

  Copper deficiency: An important consideration in the differential diagnosis of myelodysplastic syndrome

  Fong, T., Vij, R., Vijayan, A., DiPersio, J. & Blinder, M., Oct 2007, In: Haematologica. 92, 10, p. 1429-1430 2 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Myelodysplastic Syndromes 100%
  • Copper 88%
  • Differential Diagnosis 68%
  • Developmental Bone Disease 33%
  • Gastrointestinal Diseases 23%
  33 Scopus citations

• Rituximab for the treatment of patients with very high-titre acquired factor VIII inhibitors refractory to conventional chemotherapy

  Field, J. J., Fenske, T. S. & Blinder, M. A., Jan 1 2007, In: Haemophilia. 13, 1, p. 46-50 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Factor VIII 100%
  • Rituximab 96%
  • Drug Therapy 52%
  • Plasmapheresis 17%
  • Vincristine 16%
  34 Scopus citations

• Shoulder arthroplasty in sickle cell patients with humeral head avascular necrosis

  Lau, M. W., Blinder, M. A., Williams, K. & Galatz, L. M., Mar 2007, In: Journal of Shoulder and Elbow Surgery. 16, 2, p. 129-134 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Humeral Head 100%
  • Arthroplasty 72%
  • Shoulder 69%
  • Necrosis 58%
  • Hemiarthroplasty 25%
  18 Scopus citations
• 2006

  Considerations in the evaluation of haemophilia patients for short-term prophylactic therapy: A paediatric and adult case study

  Luchtman-Jones, L., Valentino, L. A., Manno, C., Allen, G., Blinder, M., Boggio, L., Brown, C., Cohen, A., Fu, K., Jeng, M., Kobrinsky, N., Kraut, E., Kulkarni, R., Lusher, J., Mathew, P., Matthews, D., Pipe, S., Quon, D., Raj, A., Ramdas, J., & 5 othersSabio, H., Sieger, L., Tapper, M., Ungar, D. & Wickland, B., Jan 2006, In: Haemophilia. 12, 1, p. 82-86 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Hemophilia A 100%
  • Hemorrhage 57%
  • Pediatrics 56%
  • Blood Coagulation Factors 50%
  • Wounds and Injuries 42%
  10 Scopus citations

• Immunosuppressive therapy for acute porphyria: Safety and efficacy in a patient with bone marrow failure

  Field, J. J., Giannone, L., Bessler, M. & Blinder, M. A., Nov 2006, In: Pharmacotherapy. 26, 11, p. 1662-1666 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Acute Intermittent Porphyria 100%
  • Bone Marrow Failure Disorders 92%
  • Immunosuppressive Agents 56%
  • Cyclosporine 45%
  • Safety 39%
  1 Scopus citations
• 2004

  Dominant factor XI deficiency caused by mutations in the factor XI catalytic domain

  Kravtsov, D. V., Wu, W., Meijers, J. C. M., Sun, M. F., Blinder, M. A., Dang, T. P., Wang, H. & Gailani, D., Jul 1 2004, In: Blood. 104, 1, p. 128-134 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Factor XI Deficiency 100%
  • Factor XI 88%
  • Catalytic Domain 55%
  • Mutation 51%
  • Polypeptide 50%
  77 Scopus citations

• Subcutaneous lepirudin for heparin-induced thrombocytopenia and when other anticoagulants fail: illustrative cases.

  Deitcher, S. R., Ngengwe, R., Kaplan, R., Liebman, H., Kaplan, K. & Blinder, M., Jun 2004, In: Clinical advances in hematology & oncology : H&O. 2, 6, p. 382-384; discussion 384-386

  Research output: Contribution to journal › Article › peer-review

  4 Scopus citations
• 2003

  Remission of chronic thrombotic thrombocytopenic purpura after treatment with cyclophosphamide and rituximab

  Zheng, X., Pallera, A. M., Goodnough, L. T., Sadler, J. E. & Blinder, M. A., Jan 21 2003, In: Annals of internal medicine. 138, 2, p. 105-108 4 p.

  Research output: Contribution to journal › Article › peer-review

  • Thrombotic Thrombocytopenic Purpura 100%
  • Rituximab 80%
  • Cyclophosphamide 69%
  • Plasma Exchange 25%
  • Immunosuppressive Agents 17%
  128 Scopus citations
• 2002

  Clinical utility of the reticulocyte hemoglobin content in the diagnosis of iron deficiency

  Mast, A. E., Blinder, M. A., Lu, Q., Flax, S. & Dietzen, D. J., Feb 15 2002, In: Blood. 99, 4, p. 1489-1491 3 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Cellular Volume 100%
  • Reticulocytes 66%
  • Hemoglobin 51%
  • Iron 46%
  • Hemoglobins 44%
  185 Scopus citations
• 2001

  Extreme warfarin sensitivity in siblings associated with multiple cytochrome P450 polymorphisms

  Tabrizi, A. R., McGrath, S. D., Blinder, M. A., Buchman, T. G., Zehnbauer, B. A. & Freeman, B. D., 2001, In: American journal of hematology. 67, 2, p. 144-146 3 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Warfarin Sensitivity 100%
  • Warfarin 58%
  • Cytochrome P-450 Enzyme System 54%
  • Genetic Testing 19%
  • Genotype 13%
  13 Scopus citations

• Population differences in von Willebrand factor levels affect the diagnosis of von Willebrand disease in African-American women

  Tabrizi, A. R., McGrath, S. D., Blinder, M. A., Buchman, T. G., Zehnbauer, B. A. & Freeman, B. D., 2001, In: American journal of hematology. 67, 2, p. 125-129 5 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • von Willebrand Diseases 100%
  • von Willebrand Factor 82%
  • African Americans 70%
  • Population 29%
  • factor VIII, von Willebrand factor drug combination 17%
  73 Scopus citations
• 2000

  Successful electroconvulsive therapy given to a patient with von Willebrand's disease

  Sincoff, R. C., Giuffra, L. A., Blinder, M. A. & Isenberg, K. E., 2000, In: Journal of ECT. 16, 1, p. 68-70 3 p.

  Research output: Contribution to journal › Article › peer-review
  2 Scopus citations
• 1999

  Acute promyelocytic leukemia with additional chromosomal abnormalities and absence of Auer rods

  Kaleem, Z., Watson, M. S., Zutter, M. M., Blinder, M. A. & Hess, J. L., 1999, In: American journal of clinical pathology. 112, 1, p. 113-118 6 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Acute Promyelocytic Leukemia 100%
  • Chromosome Aberrations 77%
  • Granulocyte Precursor Cells 69%
  • Acute Myeloid Leukemia 50%
  • Bone Marrow 39%
  12 Scopus citations

• Donor-derived acute promyelocytic leukemia in a liver-transplant recipient

  Bodó, I., Peters, M., Radich, J. P., Hess, J., Blinder, M., Watson, M. S., Van Rheeden, R., Natarajan, S., Lowell, J. A., Brown, R., DiPersio, J. & Adkins, D., Sep 9 1999, In: New England Journal of Medicine. 341, 11, p. 807-813 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  51 Scopus citations
• 1998

  Allosteric effects of a monoclonal antibody against thrombin exosite II

  Colwell, N. S., Blinder, M. A., Tsiang, M., Gibbs, C. S., Bock, P. E. & Tollefsen, D. M., Oct 27 1998, In: Biochemistry. 37, 43, p. 15057-15065 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Thrombin 100%
  • Immunoglobulin G 70%
  • Monoclonal Antibodies 68%
  • Glycine Residue 21%
  • Antithrombin 19%
  32 Scopus citations

• Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations

  Mast, A. E., Blinder, M. A., Gronowski, A. M., Chumley, C. & Scott, M. G., Jan 31 1998, In: Clinical chemistry. 44, 1, p. 45-51 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Ferritin 100%
  • Transferrin Receptors 98%
  • Ferritins 84%
  • Serum 36%
  • Population 31%
  384 Scopus citations

• HPLC detection of fetal blood in meconium: Improved sensitivity compared with qualitative methods

  Chen, D., Wilhite, T. R., Smith, C. H., Blinder, M. A. & Landt, M., 1998, In: Clinical chemistry. 44, 11, p. 2277-2280 4 p.

  Research output: Contribution to journal › Article › peer-review

  • Meconium 100%
  • Fetal Blood 75%
  • Hemoglobin 70%
  • High Pressure Liquid Chromatography 62%
  • Hemoglobins 61%
  5 Scopus citations
• 1997

  Identification of a monoclonal thrombin inhibitor associated with multiple myeloma and a severe bleeding disorder

  Colwell, N. S., Tollefsen, D. M. & Blinder, M. A., 1997, In: British Journal of Haematology. 97, 1, p. 219-226 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Thrombin Time 100%
  • Thrombin 83%
  • Multiple Myeloma 83%
  • Immunoglobulin G 63%
  • Hemorrhage 54%
  42 Scopus citations
• 1996

  Multimodality therapy of an acquired factor V inhibitor

  Fu, Y. X., Kaufman, R., Rudolph, A. E., Collum, S. E. & Blinder, M. A., Apr 1996, In: American journal of hematology. 51, 4, p. 315-318 4 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Factor V 100%
  • Plasma Exchange 38%
  • Hemorrhage 30%
  • Platelet Transfusion 19%
  • Plasmapheresis 18%
  34 Scopus citations
• 1991

  Complete Nucleotide Sequence of the Gene for Human Heparin Cofactor II and Mapping to Chromosomal Band 22q11

  Herzog, R., Lutz, S., Blin, N., Marasa, J. C., Blinder, M. A. & Tollefsen, D. M., Feb 1 1991, In: Biochemistry. 30, 5, p. 1350-1357 8 p.

  Research output: Contribution to journal › Article › peer-review

  • human SERPIND1 protein 100%
  • Heparin Cofactor II 65%
  • Nucleotide Sequence 58%
  • Heparin 49%
  • Cofactor 43%
  29 Scopus citations

• Role of lysine 173 in heparin binding to heparin cofactor II

  Whinna, H. C., Blinder, M. A., Szewczyk, M., Tollefsen, D. M. & Church, F. C., 1991, In: Journal of Biological Chemistry. 266, 13, p. 8129-8135 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Heparin Cofactor II 100%
  • Dermatan Sulfate 78%
  • Heparin 63%
  • Lysine 60%
  • Cofactor 56%
  58 Scopus citations
• 1990

  Site-directed mutagenesis of arginine 103 and lysine 185 in the proposed glycosaminoglycan-binding site of heparin cofactor II

  Blinder, M. A. & Tollefsen, D. M., 1990, In: Journal of Biological Chemistry. 265, 1, p. 286-291 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Heparin Cofactor II 100%
  • Site-Directed Mutagenesis 66%
  • Glycosaminoglycans 65%
  • Heparin 63%
  • Arginine 61%
  49 Scopus citations

• Substitution of arginine for Leu⁴⁴⁴ in the reactive site of heparin cofactor II enhances the rate of thrombin inhibition

  Derechin, V. M., Blinder, M. A. & Tollefsen, D. M., 1990, In: Journal of Biological Chemistry. 265, 10, p. 5623-5628 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Heparin Cofactor II 100%
  • Inhibition of Thrombin 95%
  • Dermatan Sulfate 71%
  • Heparin 63%
  • Arginine 61%
  46 Scopus citations
• 1989

  Heparin cofactor II(Oslo). Mutation of Arg-189 to His decreases the affinity for dermatan sulfate

  Blinder, M. A., Andersson, T. R., Abildgaard, U. & Tollefsen, D. M., 1989, In: Journal of Biological Chemistry. 264, 9, p. 5128-5133 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Heparin Cofactor II 100%
  • Dermatan Sulfate 86%
  • Heparin 63%
  • Cofactor 56%
  • Mutation 52%
  68 Scopus citations

• Relapse of acute leukemia after marrow transplantation: Natural history and results of subsequent therapy

  Mortimer, J., Blinder, M. A., Schulman, S., Appelbaum, F. R., Buckner, C. D., Clift, R. A., Sanders, J. E., Storb, R. & Thomas, E. D., Jan 1 1989, In: Journal of Clinical Oncology. 7, 1, p. 50-57 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Natural History 100%
  • Leukemia 81%
  • Transplantation 75%
  • Bone Marrow 72%
  • Recurrence 56%
  171 Scopus citations
• 1988

  Heparin Cofactor II: cDNA Sequence, Chromosome Localization, Restriction Fragment Length Polymorphism, and Expression in Escherichia Coli

  Blinder, M. A., Marasa, J. C., Reynolds, C. H., Deaven, L. L. & Tollefsen, D. M., Jan 1 1988, In: Biochemistry. 27, 2, p. 752-759 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Heparin Cofactor II 100%
  • Complementary DNA 64%
  • Heparin 63%
  • Restriction Fragment Length Polymorphisms 60%
  • Cofactor 56%
  72 Scopus citations
• 1987

  Comparison of double beta-lactam antibiotics (cefoperazone/mezlocillin or cefoperazone/piperacillin) with ticarcillin/tobramycin/cefazolin in febrile neutropenic patients

  Mortimer, J. E., Blinder, M. A. & Black, D., Jan 1 1987, In: Current Therapeutic Research - Clinical and Experimental. 42, 1, p. 25-33 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Mezlocillin 100%
  • Ticarcillin 92%
  • Cefoperazone 86%
  • Piperacillin 84%
  • Cefazolin 81%
  1 Scopus citations
• 1983

  Brain metastasis from esophageal carcinoma

  Averbuch, S. D. & Blinder, M. A., 1983, In: CA: A Cancer Journal for Clinicians. 33, 3, p. 164-166 3 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Carcinoma 100%
  • Neoplasm Metastasis 93%
  • Brain 74%
  12 Scopus citations

• The action of thrombin on peptide p-Nitroanilide substrates. Substrate selectivity and examination of hydrolysis under different reaction condtions

  Lottenberg, R., Hall, J. A., Blinder, M., Binder, E. P. & Jackson, C. M., Feb 15 1983, In: Biochimica et Biophysica Acta (BBA)/Protein Structure and Molecular. 742, 3, p. 539-557 19 p.

  Research output: Contribution to journal › Article › peer-review

  • Thrombin 100%
  • Hydrolysis 86%
  • Proline 64%
  • Arginine 62%
  • Peptides 59%
  114 Scopus citations